Meta-analytic comparison of randomized and nonrandomized studies of breast cancer surgery

Canadian Journal of Surgery

Volumn 55, Issue 3, 2012, Pages 155-162

  Edwards, Janet P ^a   Kelly, Elizabeth J ^a   Lin, Yongtao ^b   Lenders, Taryn ^b   Ghali, William A ^c,d   Graham, Andrew J ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b Health Information Network Calgary   (Canada)

^c Department of Medicine   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; FEMALE; HUMAN; MASTECTOMY; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MASTECTOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84863523148     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.023410     Document Type: Article

References (53)

1. McCormack K, Scott NW, Go PM, et al. Collaboration the EU Hernia Trialists. Laparoscopic techniques versus open techniques for inguinal hernia repair. Cochrane Database Syst Rev 2008;1:CD001785 10.1002 /14651858.
2. Horton R. Surgical research or comic opera: questions, but few answers. Lancet 1996;347:984-5. (Pubitemid 26112164)
3. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92. (Pubitemid 30419054)
4. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86. (Pubitemid 30419053)
5. Ioannidis JP, Haidich AB, Pappa M, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-30. (Pubitemid 33015576)
6. Shikata S, Nakayama T, Noguchi Y, et al. Comparison of effects in randomized controlled trials with observational studies in digestive surgery. Ann Surg 2006;244:668-76. (Pubitemid 44629938)
7. McLeod RS. Issues in surgical randomized controlled trials. World J Surg 1999;23:1210-4. (Pubitemid 29530461)
8. Hall JC, Mills B, Nguyen N, et al. Methodologic standards in surgical trials. Surgery 1996;119:466-72. (Pubitemid 26115842)
9. Lin J, Wilbur WJ. PubMed related articles: a probabilistic topicbased model for content similarity. BMC Bioinformatics 2007;8:423.
10. Barraclough H, Govindan R. Biostatistics primer: what a clinician ought to know: subgroup analyses. J Thorac Oncol 2010;5:741-6.
11. Freeman SR, Washington SJ, Pritchard T, et al. Long term results of a randomised prospective study of preservation of the intercostobrachial nerve. Eur J Surg Oncol 2003;29:213-5. (Pubitemid 36395553)
12. Torresan RZ, Cabello C, Conde DM, et al. Impact of the preservation of the intercostobrachial nerve in axillary lymphadenectomy due to breast cancer. Breast J 2003;9:389-92. (Pubitemid 37158913)
13. Nishiki M, Yamane M, Amano K, et al. Evaluation of intercostobrachial nerve preservation in modified radical mastectomy for breast cancer - preliminary report on sensory disturbance test results. Hiroshima J Med Sci 1984;33:559-62. (Pubitemid 15218768)
14. Paredes JP, Puente JL, Potel J. Variations in sensitivity after sectioning the intercostobrachial nerve. Am J Surg 1990;160:525-8. (Pubitemid 20375617)
15. Taylor KO. Morbidity associated with axillary surgery for breast cancer. ANZ J Surg 2004;74:314-7. (Pubitemid 38703718)
16. Temple WJ, Ketcham AS. Preservation of the intercostobrachial nerve during axillary dissection for breast cancer. Am J Surg 1985; 150: 585-8. (Pubitemid 16199775)
17. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98:599-609. (Pubitemid 43904843)
18. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983-90. (Pubitemid 44804136)
19. Zavagno G, De Salvo GL, Scalco G, et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissectionin breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008;247:207-13. (Pubitemid 351156760)
20. Haid A, Knauer M, Koberle-Wuhrer R, et al. Medium-term followup data after sentinel node biopsy alone for breast cancer. Eur J Surg Oncol 2006;32:1180-5. (Pubitemid 44793674)
21. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-9. (Pubitemid 30432521)
22. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of xillary lymph node dissection: a follow-up study of 4008 proced - ures. Ann Surg 2004;240:462-8; discussion 468-71.
23. Takei H, Suemasu K, Kurosumi M, et al. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast Cancer 2007;14:16-24.
24. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006;95:279-93.
25. Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 2005;23:4312-21. (Pubitemid 46209968)
26. Husen M, Paaschburg B, Flyger HL. Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 2006;15:620-8. (Pubitemid 44509772)
27. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up ofa randomized study comparing breast-conserving surgery with rad - ical mastectomy for early breast cancer. N Engl J Med 2002;347: 1227-32. (Pubitemid 35176241)
28. Arriagada R, Le MG, Guinebretiere JM, et al. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 2003;14:1617-22. (Pubitemid 37455809)
29. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98:697-702. (Pubitemid 36959264)
30. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41. (Pubitemid 35176242)
31. Fan J, Wang L, Wang XJ, et al. Breast conservative therapy in east part of China: a retrospective cohort study. J Cancer Res Clin Oncol 2006; 132:573-8. (Pubitemid 44078526)
32. Hermann RE, Esselstyn CB Jr, Grundfest-Broniatowski S, et al. Partial mastectomy without radiation is adequate treatment for patients with stages 0 and I carcinoma of the breast. Surg Gynecol Obstet 1993; 177:247-53. (Pubitemid 23262671)
33. Kindermann G, Genz T. A comparison between the results of simple mastectomy and tumorectomy for breast cancer: the problem of local recurrence. Arch Gynecol 1985;237:67-73. (Pubitemid 16191694)
34. Noguchi M, Yagasaki R, Kawahara F, et al. Breast conserving treatment versus modified radical mastectomy in Japanese patients with operable breast cancer. Int Surg 1997;82:289-94. (Pubitemid 27483003)
35. Rauschecker HF, Sauerbrei W, Gatzemeier W, et al. Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). Eur J Cancer 1998;34:315-23. (Pubitemid 28183827)
36. Rissanen PM. A comparison of conservative and radical surgery combined with radiotherapy in the treatment of stage I carcinoma of the breast. Br J Radiol 1969;42:423-6.
37. Romsdahl MM, Montague ED, Ames FC, et al. Conservation surgery and irradiation as treatment for early breast cancer. Arch Surg 1983; 118:521-8. (Pubitemid 13079288)
38. Voogd AC, Nab HW, Crommelin MA, et al. Comparison of breastconserving therapy with mastectomy for treatment of early breast cancer in community hospitals. Eur J Surg Oncol 1996;22:13-6. (Pubitemid 26121685)
39. Devitt JE. The influence of conservative and radical surgery on the survival of patients with breast cancer. Can Med Assoc J 1962;87: 906-10.
40. Halverson KJ, Taylor ME, Perez CA, et al. Survival following breastconserving surgery and irradiation or modified radical mastectomy in patients with invasive breast cancers with a maximum diameter of 1 cm. Mo Med 1993;90:759-63.
41. Geiger AM, Thwin SS, Lash TL, et al. Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer 2007;109:966-74. (Pubitemid 46333538)
42. Matthews RH, McNeese MD, Montague ED, et al. Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int J Radiat Oncol Biol Phys 1988;14:659-63.
43. Freitas-Júnior R, Oliveira EL, Pereira RJ, et al. Modified radical mastectomy sparing one or both pectoral muscles in the treatment of breast cancer: intra and postoperative complications. Sao Paulo Med J 2006;124:130-4. (Pubitemid 44420511)
44. Markandoo P, Smith P, Chaudary MA, et al. Preservation of pectoralis minor in axillary clearance for breast cancer. Br J Surg 1998;85:1547-8. (Pubitemid 28502589)
45. Muscolino G, Leo E, Sacchini V, et al. Resectable breast cancer: axillary dissection sparing pectoralis muscles and nerves. Eur J Surg Oncol 1988;14:429-33. (Pubitemid 18263433)
46. Hoefer RA Jr, DuBois JJ, Ostrow LB, et al. Wound complications following modified radical mastectomy: an analysis of perioperative factors. J Am Osteopath Assoc 1990;90:47-53. (Pubitemid 20035791)
47. Arriagada R, Le MG, Contesso G, et al. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 2002;13:1404-13.
48. Dunn MJ, Tartter PI. Comparison of mastectomy and lumpectomy for medial carcinoma of the breast. Surg Gynecol Obstet 1991;173: 13-6.
49. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel- lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007;8:881-8. (Pubitemid 47488052)
50. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol2007;25:3657-63.
51. Dalberg K, Johansson H, Signomklao T, et al. A randomised study of axillary drainage and pectoral fascia preservation after mastectomy for breast cancer. Eur J Surg Oncol 2004;30:602-9. (Pubitemid 39060728)
52. McCulloch P, Altman DG, Campbell WB, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009;374:1105-12.
53. MacLehose RR, Reeves BC, Harvey IM, et al. A systematic review of comparisons of effect sizes derived from randomised and nonrandomized studies. Health Technol Assess 2000;4:1-154.